📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting influenza vaccine antigens to antigen presenting cells

Lead Research Organisation: THE PIRBRIGHT INSTITUTE
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The generation of protective immune responses as early as possible in the life of the perinatal bird is a critical practical issue as pathogen challenge may occur at hatch. The targeting of vaccine antigens to dendritic cells (DC) may be used to provoke stronger and faster immune responses than are achieved with conventional vaccines. This project will seek to produce sterile immunity to avian viruses in hatchling chickens. Approaches reported in the mammalian literature include targeting specific DC cell surface molecules with either constructs of antigen-DC ligand or with specifically modified recombinant vaccine viruses. These approaches have not been reported in poultry, partly due to a lack of appropriate APC-specific reagents. The recent cloning of APC-specific molecules have now provided the tools both for targeting and the subsequent analysis of immune responses. We will initially target CD40, a costimulatory molecule cloned in John Young’s lab, and DEC 205 an endocytosis receptor cloned in this lab. This project will apply these strategies to the potentiation of vaccination against avian influenza virus (AIV). Targetting molecules will include both monoclonal antibodies and fusion proteins. These will be linked with relevant avian influenza virus antigens, and used to vaccinate chicks. Cellular and humoral immune responses will be measured and chicks challenged with low and high pathogenicity avian influenza virus.
Modification of vaccines viruses better to target DCs will be explored in collaboration with Adrian Hill’s group at Oxford. Recombinant adenovirus will be produced to include AIV genes and will utilise DC ligands to enhance the transduction of chicken DCs in vivo. It is anticipated that this project will provide data that will be used in further grant applications and approaches to industrial partners.

Planned Impact

unavailable

Publications

10 25 50

 
Description We have, for the first time, provided immunological tools to investigate antigen presenting cells within a bird. We have also designed a novel vaccine to protect chickens against avian influenza infection.
Exploitation Route The development of further understanding and also of novel vaccines.
Sectors Agriculture

Food and Drink

 
Description Our findings have been used in further study to understand the development of immune responses in avian species and also in the design of novel vaccines.
First Year Of Impact 2012
Sector Agriculture, Food and Drink
 
Description Interviews 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Many television and radio interviews in the area of avian influenza and particularly my research. Both national and local media.
Year(s) Of Engagement Activity 2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018